A PILOT STUDY TO EVALUATE NUCLEIC ACID AMPLIFICATION TESTS TO PREDICT TB RELAPSE

评估核酸扩增测试预测结核病复发的试点研究

基本信息

  • 批准号:
    7627501
  • 负责人:
  • 金额:
    $ 0.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2008-03-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. OBJECTIVE: The aim of this study is to determine the utility of different nucleic acid amplification and broth culture tests obtained early in treatment and in the post-treatment periods to predict subsequent relapse of tuberculosis. Bacillary burden and MTB viability will be measured: in sputa by quantitative rRNA, qualitative (MTD Gen-Probe) rRNA, mRNA; 'time to positivity' in broth cultures; and in circulating leukocytes ("burry coat" specimens) by MTB DNA. RESEARCH PLAN: The study design is a blinded retrospective evaluation of specimens obtained in the course of two multi-center TB treatment trials. This is a CDC sponsored study. Inclusion criteria are (1) enrollment in TBTC / USPHS Trials 23 or 24, and (2) provision of written informed consent.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARC H WEINER其他文献

MARC H WEINER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARC H WEINER', 18)}}的其他基金

STUDY 26PK, RIFAPENTINE PKS IN CHILDREN RECEIVING WEEKLY ISONIAZID FOR TB (HIV)
研究 26PK,利福喷汀 PKS 在每周接受异烟肼治疗结核病 (HIV) 的儿童中的应用
  • 批准号:
    7718711
  • 财政年份:
    2008
  • 资助金额:
    $ 0.79万
  • 项目类别:
PHARMACOKINETIC ISSUES IN THE USE OF MOXIFLOXACIN FOR TREATMENT OF TUBERCULOSIS
使用莫西沙星治疗结核病的药代动力学问题
  • 批准号:
    7718709
  • 财政年份:
    2008
  • 资助金额:
    $ 0.79万
  • 项目类别:
CLINICAL TRIAL: RIFAPENTINE/ISONIAZID FOR 3 MONTHS VS 9 MO FOR LATENT TB (STUDY
临床试验:利福喷丁/异烟肼治疗潜伏性结核病 3 个月与 9 个月(研究
  • 批准号:
    7718707
  • 财政年份:
    2008
  • 资助金额:
    $ 0.79万
  • 项目类别:
CLINICAL TRIAL: EVAL OF A MOXIFLOXACIN-BASED REGIMEN FOR TB TREATMENT, STUDY 28
临床试验:评估基于莫西沙星的结核病治疗方案,研究 28
  • 批准号:
    7718710
  • 财政年份:
    2008
  • 资助金额:
    $ 0.79万
  • 项目类别:
A PILOT STUDY TO EVALUATE NUCLEIC ACID AMPLIFICATION TESTS TO PREDICT TB RELAPSE
评估核酸扩增测试预测结核病复发的试点研究
  • 批准号:
    7718708
  • 财政年份:
    2008
  • 资助金额:
    $ 0.79万
  • 项目类别:
PHARMACOKINETIC ISSUES IN THE USE OF MOXIFLOXACIN FOR TREATMENT OF TUBERCULOSIS
使用莫西沙星治疗结核病的药代动力学问题
  • 批准号:
    7627503
  • 财政年份:
    2007
  • 资助金额:
    $ 0.79万
  • 项目类别:
AN EVAL OF ACTIVITY AND TOLERABILITY OF MOXIFLOXACIN IN TX FOR TB-STUDY 27 (HIV)
德克萨斯州莫西沙星对 TB-Study 27 (HIV) 的活性和耐受性评估
  • 批准号:
    7627502
  • 财政年份:
    2007
  • 资助金额:
    $ 0.79万
  • 项目类别:
RIFAPENDINE/ISONIAZID FOR 3 MONTHS VS 9 MO FOR LATENT TB (STUDY 26) (HIV)
利福平/异烟肼 3 个月与 9 个月治疗潜伏性结核病(研究 26)(HIV)
  • 批准号:
    7627500
  • 财政年份:
    2007
  • 资助金额:
    $ 0.79万
  • 项目类别:
EVAL OF A MOXIFLOXACIN-BASED REGIMEN FOR TB TREATMENT, STUDY 28 (HIV)
基于莫西沙星的结核病治疗方案的评估,研究 28(HIV)
  • 批准号:
    7627504
  • 财政年份:
    2007
  • 资助金额:
    $ 0.79万
  • 项目类别:
IMPACT OF CHRONIC VIRAL HEPATITIS ON PT D/C OF TX FOR LATENT TB-STUDY 26A (HIV)
慢性病毒性肝炎对 TX 潜伏结核病 PT D/C 的影响-研究 26A (HIV)
  • 批准号:
    7627499
  • 财政年份:
    2007
  • 资助金额:
    $ 0.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了